Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225 37. S4.3.2-9. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the pre- vention of sudden death in patients with coronary artery disease. CLINICAL STATEMENTS AND GUIDELINES Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882 90. S4.3.2-10. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933 40. S4.3.2-11. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejec- tion fraction. N Engl J Med. 2002;346:877 83. S4.3.2-12. Bhandari AK, Shapiro WA, Morady F, et al. Electrophysiologic testing in patients with the long QT syndrome. Circulation. 1985;71:63 71. S4.3.2-13. Giustetto C, Di MF, Wolpert C, et al. Short QT syndrome: clini- cal findings and diagnostic-therapeutic implications. Eur Heart J. 2006;27:2440 7. S4.3.2-14. Giustetto C, Schimpf R, Mazzanti A, et al. Long-term follow- up of patients with short QT syndrome. J Am Coll Cardiol. 2011;58:587 95. S4.3.2-15. Mahida S, Derval N, Sacher F, et al. Role of electrophysiological stud- ies in predicting risk of ventricular arrhythmia in early repolarization syndrome. J Am Coll Cardiol. 2015;65:151 9. S4.3.2-16. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69 74. S4.3.2-17. Gatzoulis KA, Vouliotis AI, Tsiachris D, et al. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stim- ulation. Circ Arrhythm Electrophysiol. 2013;6:504 12. S4.3.2-18. Brembilla-Perrot B, Suty-Selton C, Beurrier D, et al. 